Funded Tech Companies
Rome Therapeutics
Researching who backed Rome Therapeutics? Sanofi-Genzyme BioVentures, GV and Alexandria Venture Investments joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Rome Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
700 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome -- vast stretches of uncharted genetic material that have long been dismissed as "junk DNA." With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/15/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rosana Kapeller
Chief Scientific Officer
Dennis Zaller
Vice President
David Proia
Vice President
Donna Romero
VP - Bus. Development
Wenyan Miao
VP - Finance
Kira Nelson
VP - Operations
Christine Loggins
Company Investors
- Sanofi-Genzyme BioVentures (James Trenkle)
- GV
- Alexandria Venture Investments
- Section 32 (Steven Kafka)
- Arch Venture Partners
- Andreessen Horowitz
- Casdin Capital
- Mass General Brigham Innovation
- Partners Innovation Fund
Browse more funded tech companies:
Romark Laboratories | Romeo Delivers
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs